Relationship between tumor response and the gene expression in Gimeracil/oteracil/tegafur or Tegafur-uracil /Leucovorin treated patients with locally advanced rectal cancer
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Folinic acid (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Tegafur/uracil (Primary)
- Indications Rectal cancer
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms 15R-153; SN15-011
- 01 Jun 2017 Results published in the Cancer Chemotherapy and Pharmacology.
- 01 Dec 2016 New trial record
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress.